None listed
Conditions
Brief summary
Improvements to transplant outcomes are made possible through access to high quality clinical information and biological samples. Clinical information can be used to identify areas to improve patient care, inform clinical guidelines and to provide insights into problems about how to diagnose and treat diseases. The TRIBE aims to improve transplant outcomes by developing a transplant-related registry of clinical information linked with biological samples (e.g. blood, urine) which can be used to inform quality improvement activities and to support transplant-related research.
Interventions
The TRIBE is a multicenter clinical registry and biobank which will prospectively collect and store clinical data and samples from transplant recipients. Clinical data and high-quality stored biospecimens will be linked, allowing improvements in the delivery of clinical care and support for translational and basic science research. TRIBE will collect the following data from transplant recipients: patient demographics, medical history, diagnoses leading to transplant, timing of transplant surgery, previous transplant history, donor details and post-transplant complications. Samples that may be collected from transplant recipients include bloods, stool, urine, saliva, cerebrospinal fluid, bronchoscopy samples, colonoscopy samples and allograft biopsy samples. In addition, TRIBE will collect clinical information about organ donors and link to enrolled participants for the purpose of reporting donor-derived infections. A waiver of consent will be sought for organ donors and clinical information about organ donors will be obtained via Donate Life Victoria (DLV). For transplant recipients, there are two pathways to that data and/or samples can be submitted to the TRIBE: (1) routine collection of data and/or samples at pre-determined times (e.g. pre-transplant, >100 days post-transplant, >12 months post-transplant) and (2) event-driven collection of additional clinical data and/or samples [e.g. at time cytomegalovirus (CMV) disease is diagnosed].
Sponsors
Eligibility
Inclusion criteria
All transplant recipients. Patients who are waitlisted or under evaluation for transplant. All organ donors
Exclusion criteria
None